Acro Biomedical (ACBM) Market Capitalization (2018 - 2026)

Acro Biomedical has reported Market Capitalization for 9 years, with the latest figure at $1.8 million in Q2 2026.

• On a quarterly basis, Market Capitalization changed N/A year-over-year to $1.8 million in Q2 2026; TTM through Jun 2026 was $1.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $955200.0, changed N/A from the prior year.
• Market Capitalization was $1.8 million for Q2 2026 at Acro Biomedical, up from $1.2 million in the prior quarter.
• The five-year high for Market Capitalization was $270.2 million in Q4 2022, with the low at $1.2 million in Q4 2025.
• Average Market Capitalization over 5 years is $120.0 million, with a median of $79.6 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Market Capitalization soared 100.82% in 2022, then slumped 97.78% in 2023.
• Over 5 years, Market Capitalization stood at $270.2 million in 2022, then plunged by 97.78% to $6.0 million in 2023, then changed by 0.0% to $6.0 million in 2024, then sank by 80.0% to $1.2 million in 2025, then soared by 50.0% to $1.8 million in 2026.
• The last three Market Capitalization figures came in at $1.8 million (Q2 2026), $1.2 million (Q4 2025), and $6.0 million (Q2 2024), per Business Quant data.